IL-17F plays a significant role in inflammatory responses and offers protection at barrier surfaces, as demonstrated by the increased susceptibility to chronic mucocutaneous candidiasis in individuals with an autosomal dominant deficiency of IL-17F [124]. Here, IL17F is linked to Chronic mucocutaneous candidosis.